Authors combined several transcriptomics and proteomics datasets obtained during the analysis of AD-related transgenic (with the presence of mutations in genes involved in amyloid and tau aggregation and processing) mouse models and GWAS AD-related orthologs through the implementation of DE (differential expression) analysis steps and Gene Ontology (GO) mapping. This evidence concerns the gene MAPT and Alzheimer disease.